The stock ticker symbol RCEL represents fractional equity ownership in AVITA Medical, Inc., a commercial-stage regenerative medicine enterprise. Purchasing shares allows public investors to gain financial exposure to the company's proprietary medical device portfolio, intellectual property assets, global commercial distribution network, and future revenue growth derived from advanced tissue-restoration and wound-care technologies.